MDLN Medline Inc.

37.84USD-3.37%Mkt Cap: 49.80B USDP/E: 86.00

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through tw…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap49.80B USD
Enterprise Value51.02B USD
Revenue (TTM)30.68B USD
Gross Profit7.52B USD
Net Income (TTM)1.16B USD
Revenue/Share34.90 USD
Last Price37.84 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees45.0K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)86.00
P/E (Forward)24.50
PEG—
EV/EBITDA18.92
EV/Revenue1.66
P/S1.62
P/B2.82
EPS (TTM)0.44 USD
EPS (Forward)1.54 USD
52W Range
31.3733% of range50.88
52W High50.88 USD
52W Low31.37 USD
Profitability
Gross Margin26.44%
Oper. Margin5.43%
EBITDA Margin8.79%
Profit Margin4.08%
ROE10.79%
ROA3.01%
ROIC6.84%
ROCE6.15%
Growth
Revenue Growth10.40%
Earnings Growth1087.70%
Cash Flow & Leverage
Operating CF1.74B USD
CapEx (TTM)447.00M USD
FCF Margin4.53%
FCF Yield2.79%
Net Debt9.03B USD
Net Debt/EBITDA3.35
Net Debt/FCF6.49
Balance Sheet
Debt/Equity1.18
Current Ratio4.04
Quick Ratio2.37
Book Value/Sh13.43 USD
Cash/Share4.12 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)45.61 USD
Upside (mean)+20.5%
Target Range34.00 USD – 55.00 USD
34.00+20.5% to mean55.00
# Analysts23
Ownership
Shares Out.878.66M
Float382.03M
Insiders0.26%
Institutions113.20%
Short Interest
Short Ratio4.2d
Short % Float8.95%
Short % Out.4.30%
Shares Short37.84M
Short (prev mo.)52.69M
Technical
SMA 5035.33 (+7.1%)
SMA 20039.35 (-3.8%)
Beta—
S&P 52W Chg12.08%
Avg Vol (30d)10.53M
Avg Vol (10d)11.27M
Technical Indicators
RSI (14)51.8
MACD1.0918
MACD Signal1.1451
MACD Hist.-0.0533
BB Upper44.14 USD
BB Middle37.06 USD
BB Lower29.98 USD
BB Width38.18%
ATR (14)1.724 USD
Vol Ratio (20d)0.84x

About Medline (NASDAQ: MDLN)

›

Medline (NASDAQ: MDLN) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 45,000 employees.

The shares were at 37.84 USD on 19 November 2026. Its 52-week range is 31.37 USD to 50.88 USD: the price is 25.6% below the high and 20.6% above the low.

At a market capitalisation of 49.80B USD, it trades at 86.0 times trailing earnings and 24.5 times forward earnings. The median trailing P/E of its 18 largest Medical Instruments & Supplies peers is 48.1, a premium of 79% for MDLN.

Medline reports return on equity of 10.8%, an operating margin of 5.4% and revenue up 10.4% year over year.

Its debt exceeds its cash by 9.03B USD, a debt-to-equity ratio of 1.18. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 23 analysts cover the stock, with an average rating of Buy; their mean price target of 45.61 USD is 20.5% above the current price. The next earnings report is expected on 24 February 2027.